FDA Adverse Event Injury Summary report: N

LOGIC TIBIA IMPLANT PSC INSERT, SZ 3.5, 13MM

MDR report key: 18957138 · Received March 22, 2024

Report

Report Number
1038671-2024-00637
Event Type
Injury
Date Received
March 22, 2024
Date of Event
April 7, 2022
Report Date
May 13, 2026
Manufacturer
EXACTECH, INC.
Product Code
JWH
UDI-DI
10885862173614
PMA / PMN Number
K110547
Removal / Correction Number
Z-0021-2022
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

H6. INVESTIGATION RESULTS - THE REVISION REPORTED MAY HAVE BEEN THE RESULT OF POLYETHYLENE WEAR. POSSIBLE CAUSES FOR POLYETHYLENE WEAR INCLUDE MALALIGNMENT BETWEEN THE IMPLANTS, HIGH CONTACT STRESSES DURING KNEE FLEXION, THIRD BODY WEAR, PATIENT-RELATED CONDITIONS, INSTABILITY, OR ANY COMBINATION OF THESE POSSIBILITIES. HOWEVER, THE EXTENT AND ROOT CAUSE OF THE REPORTED POLYETHYLENE WEAR CANNOT BE CONFIRMED AS THE DEVICES WERE NOT AVAILABLE FOR EVALUATION, AND RADIOGRAPHS/PHOTOGRAPHS AND OPERATIVE NOTES WERE NOT PROVIDED. THESE DEVICES ARE USED FOR TREATMENTS, NOT DIAGNOSIS. THERE IS NO OTHER INFORMATION AVAILABLE.

Additional Manufacturer Narrative · 0

D10. CONCOMITANTS: 02-012-45-3545 - LGC TIBIAL FIT TRAY CEM SZ 3.5F / 4.5T; (B)(6). 02-020-11-0335 - TRULIANT PS CEM FEM PS CEM RIGHT SZ 3.5; (B)(6). THESE DEVICES ARE USED IN TREATMENT AND NOT IN DIAGNOSIS. PENDING INVESTIGATION.

Description of Event or Problem · 0

IT WAS REPORTED VIA LEGAL DOCUMENTATION THAT A PATIENT HAD A RIGHT TOTAL KNEE ARTHROPLASTY ON (B)(6) 2018, AND THEN EXPERIENCED REVISION SURGICAL PROCEDURE ON (B)(6) 2022 APPROXIMATELY 4 YEARS AND 1 MONTH AFTER INITIAL IMPLANT. NO IMAGES WERE PROVIDED. THERE IS NO OTHER INFORMATION AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
488196 LOGIC TIBIA IMPLANT PSC INSERT, SZ 3.5, 13MM PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL JWH EXACTECH, INC. 10885862173614

Patients

Seq Age Sex Outcome Treatment
1